Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & ...
The deal, one of two multibillion-dollar buyouts from Merck this year, centers around a drug that could become an alternative ...
As families gather for Thanksgiving, here's what to know to protect your family from the new subclade K flu strain.
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
Pharmaceutical Technology on MSN
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...
Dr. Schaffner says that’s still swirling out there, too. But flu A is already making its presence known. So, what’s the d ...
UVA has launched a public-facing flu tracker, updated every Monday, to help the community monitor local trends.
Even though this flu season has been severe and the use of antiviral medication can help keep some people out of the hospital or out of the intensive care unit, such drugs are being underutilized by ...
Vitamin C can actually help cut your cold short. One 2023 meta-analysis in BMC Public Health found that vitamin C had a ...
Expert Rev Pharmacoeconomics Outcomes Res. 2008;8(6):563-573. Influenza is responsible for a great number of cases each year and, consequently, high healthcare costs. Influenza vaccination is the ...
Background The large-scale deployment of antiviral drugs from the Strategic National Stockpile during the 2009 H1N1 influenza response provides a unique opportunity to study local public health ...
HOUSTON – Houston might still feel like summer, but flu season isn’t waiting for temperatures to fall in line. Doctors say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results